|
TMED10 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.400330E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.325660E-02 |
| Normal-vs-Stage2 |
8.850200E-02 |
| Normal-vs-Stage3 |
1.113170E-01 |
| Normal-vs-Stage4 |
4.371800E-02 |
| Stage1-vs-Stage2 |
9.507800E-01 |
| Stage1-vs-Stage3 |
9.636400E-01 |
| Stage1-vs-Stage4 |
5.079000E-01 |
| Stage2-vs-Stage3 |
9.833600E-01 |
| Stage2-vs-Stage4 |
4.633600E-01 |
| Stage3-vs-Stage4 |
5.117200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.561200E-03 |
| Normal-vs-AfricanAmerican |
9.790500E-02 |
| Normal-vs-Asian |
4.506600E-01 |
| Caucasian-vs-AfricanAmerican |
6.714400E-01 |
| Caucasian-vs-Asian |
9.809800E-01 |
| AfricanAmerican-vs-Asian |
8.569400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.099400E-03 |
| Normal-vs-Female |
7.711400E-01 |
| Male-vs-Female |
7.150500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.049800E-02 |
| Normal-vs-Extreme_Weight |
9.436000E-03 |
| Normal-vs-Obese |
2.124800E-01 |
| Normal-vs-Extreme_Obese |
7.192400E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.456600E-01 |
| Normal_Weight-vs-Obese |
2.961000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.493600E-01 |
| Extreme_Weight-vs-Obese |
2.774600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.460600E-01 |
| Obese-vs-Extreme_Obese |
1.785580E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.690000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.950570E-01 |
| Normal-vs-Age(61-80Yrs) |
1.702020E-03 |
| Normal-vs-Age(81-100Yrs) |
4.937300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.794200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.263400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.494600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.945700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.138200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.296600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.773700E-02 |
| Normal-VS-Type2 PRCC |
6.434700E-04 |
| Normal-VS-KIRP CIMP |
8.400800E-01 |
| Normal-VS-Unclassified PRCC |
3.388600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.461900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.173800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.362000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.874560E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.354570E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.467800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.402560E-04 |
| Normal-vs-N1 |
2.177000E-01 |
| Normal-vs-N2 |
1.591990E-02 |
| N0-vs-N1 |
2.013200E-01 |
| N0-vs-N2 |
7.790000E-01 |
| N1-vs-N2 |
4.682400E-01 |
|
|
